Favorable long-term outcomes of one-year adjuvant S-1 monotherapy for pathological stage II or III gastric cancer treated at a high-volume center
暂无分享,去创建一个
K. Chìn | S. Ida | S. Nunobe | K. Kumagai | M. Ohashi | T. Sano | D. Takahari | Y. Kano | I. Yasufuku | N. Hiki | K. Yamaguchi | K. Eto | Yoshiaki Shoji | Y. Tsuda | K. Chin